Welcome to Join Us

Qure Bio is a biotechnology company in the clinical stage, and the first in the world to obtain clinical approvals for the targeting Claudin 18.2/PD-L1 dual-antibody in both China and the United States. The company has deep technical accumulation in the discovery and development of antibody drugs. There are currently several antibody drugs under development, and it is expected to complete preclinical studies and applied for clinical trials.

The company has strong R&D capabilities and its R&D team has many years of biopharmaceutical research experience. The company has built a complete R&D system including pre-clinical development, process development, clinical research, drug registration, etc.

Qure Bio is in a stage of rapid growth. The company has simple interpersonal relationships, harmonious working atmosphere, and provides competitive salary. Welcome to join us!